Source-grounded facts extracted from ARDELYX, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
ARDELYX, INC. reported quarter ended March 31, 2026 results: revenue Total product revenue for the quarter ended March 31, 2026 was $93.4 million, net income Net loss for the quarter ended March 31, 2026 was $37.6 million, EPS $(0.15) per share.
“Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update Q1 2026 total product revenue of $93.4 million, reflecting 38% growth year-over-year”
ARDELYX, INC.: Board adopted Second Amended and Restated Bylaws updating procedural and disclosure requirements for shareholder nominations and proposals, quorum provisions, stockholder list requirements, and adding a forum selection provision (effective 2025-08-01).
“On August 1, 2025, the Board of Directors (the “Board”) of the Company approved and adopted the Company’s Second Amended and Restated Bylaws (as amended and restated, the “Bylaws”), effective immediately.”
Merdad Parsey was appointed as Director at ARDELYX, INC..
“On April 28, 2025, the Company appointed Merdad Parsey, M.D., Ph.D, as a member of the Board of Directors (the “Board”) of Ardelyx, Inc., a Delaware corporation (the “Company”), effective immediately”
Robert Felsch changed role as senior financial advisor at ARDELYX, INC..
“Mr. Felsch will remain with the Company and will transition to a senior financial advisor role within the Company”
Joseph Reilly was appointed as Principal Accounting Officer at ARDELYX, INC..
“The Company has appointed Joseph Reilly to replace Robert Felsch in his capacity as the Company’s Principal Accounting Officer effective November 15, 2024.”
ARDELYX, INC. reported financial results for first quarter ended March 31, 2024.
“On May 2, 2024, Ardelyx, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.